Acrivon Therapeutics, Inc. 8-K

Accession 0001193125-26-085516

Filing information

CIK: 0001781174
Report date: 2026-02-25
Filing date: 2026-03-02
Form: 8-K
Primary document: d111455d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.